Enfusion Inc
NYSE:ENFN

Watchlist Manager
Enfusion Inc Logo
Enfusion Inc
NYSE:ENFN
Watchlist
Price: 11.1 USD 0.45%
Market Cap: 1.4B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+45%
Revenue
Forecast
+22%
Operating Income
Forecast
+14%
Net Income
Forecast
+24%

Wall Street
Price Targets

ENFN Price Targets Summary
Enfusion Inc

Wall Street analysts forecast ENFN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ENFN is 10.82 USD with a low forecast of 9.09 USD and a high forecast of 11.81 USD.

ENFN Lowest Forecast
Wall Street Target
9.09 USD
18% Downside
ENFN Average Forecast
Wall Street Target
10.82 USD
3% Downside
ENFN Highest Forecast
Wall Street Target
11.81 USD
6% Upside
Lowest
Price Target
9.09 USD
18% Downside
Average
Price Target
10.82 USD
3% Downside
Highest
Price Target
11.81 USD
6% Upside
Enfusion Inc Competitors:
Price Targets
FICO
Fair Isaac Corp
18% Upside
IDOX
Idox PLC
52% Upside
JAMF
Jamf Holding Corp
65% Upside
F
603383
Fujian Apex Software Co Ltd
2% Downside
FICO
Fair Isaac Corp
18% Upside
IDOX
Idox PLC
52% Upside
JAMF
Jamf Holding Corp
65% Upside
F
603383
Fujian Apex Software Co Ltd
2% Downside
CCR
Credit Clear Ltd
93% Upside
WK
Workiva Inc
38% Upside
TXT
TXT e solutions SpA
28% Upside

Revenue
Forecast

Revenue Estimate
Enfusion Inc

For the last 3 years the compound annual growth rate for Enfusion Inc's revenue is 30%. The projected CAGR for the next 4 years is 16%.

30%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Enfusion Inc

For the last 3 years the compound annual growth rate for Enfusion Inc's operating income is 25%. The projected CAGR for the next 3 years is 71%.

25%
Past Growth
71%
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Enfusion Inc

For the last 3 years the compound annual growth rate for Enfusion Inc's net income is 16%. The projected CAGR for the next 3 years is 99%.

16%
Past Growth
99%
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
ENFN intrinsic value, competitors valuation, and company profile.
DCF Valuation
ENFN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ENFN stock valuation using valuation multiples.
Wall Street Estimates
ENFN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ENFN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ENFN's stock price target?
Price Target
10.82 USD

According to Wall Street analysts, the average 1-year price target for ENFN is 10.82 USD with a low forecast of 9.09 USD and a high forecast of 11.81 USD.

What is Enfusion Inc's Revenue forecast?
Projected CAGR
16%

For the last 3 years the compound annual growth rate for Enfusion Inc's revenue is 30%. The projected CAGR for the next 4 years is 16%.

What is Enfusion Inc's Operating Income forecast?
Projected CAGR
71%

For the last 3 years the compound annual growth rate for Enfusion Inc's operating income is 25%. The projected CAGR for the next 3 years is 71%.

What is Enfusion Inc's Net Income forecast?
Projected CAGR
99%

For the last 3 years the compound annual growth rate for Enfusion Inc's net income is 16%. The projected CAGR for the next 3 years is 99%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 238,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.